3 active not recruiting, 3 completed, 3 recruiting, 1 terminated. 6 Phase 2, 3 Phase 1, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Recruiting 3, Active not recruiting 2, Completed 1 |
| Phase 1 | 3 | Recruiting 2, Completed 1 |
| Not applicable | 2 | Active not recruiting 1, Completed 1 |
Follow Core Biopsy: new trials by email Literature Review of Core Biopsy trials Research Report on Core Biopsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma Biospecimen Collection, Computed Tomography, Core Biopsy - Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 56 | 2023-03-07 | 2026-05-22 |
| Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors BET Bromodomain Inhibitor ZEN-3694, Computed Tomography, Core Biopsy - Advanced Malignant Solid Neoplasm, Locally Advanced Pancreatic Carcinoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 49 | 2022-11-16 | 2026-07-15 |
| Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast Afimoxifene, Core Biopsy, Questionnaire Administration - Cancer Survivor, Ductal Breast Carcinoma In Situ | Phase 2 | Active not recruiting | Northwestern University | 156 | 2020-02-17 | 2025-10-09 |
| Cryoablation for the Treatment of Metastatic Cancer Core Biopsy, Cryosurgery, Immunotherapeutic Agent - Metastatic Malignant Neoplasm | Not applicable | Active not recruiting | M.D. Anderson Cancer Center | 15 | 2019-12-23 | 2026-08-06 |
| A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma Computed Tomography, Core Biopsy, Magnetic Resonance Imaging - Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 23 | 2019-08-19 | 2026-07-31 |
| Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia Ascorbic Acid, Carboplatin, Cisplatin - Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Phase 2 | Recruiting | Mayo Clinic | 80 | 2018-03-23 | 2026-09-28 |
| Effectiveness of Core-Needle US Guided Biopsy as Primary Tool For Diagnosis of Thyroid Nodules FNB, Core biopsy - Thyroid Nodule, Thyroid Diseases | Not applicable | Completed | Kafrelsheikh University | 60 | 2017-01-01 | 2021-02-17 |
| Breast Cancer Molecular Analysis Protocol Core Biopsy - Metastatic Breast Cancer | Completed | Yale University | 121 | 2013-05-01 | 2016-11-17 | |
| Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma Decitabine, Temozolomide, biopsy - Malignant Melanoma | Phase 1 / Phase 2 | Completed | Hussein Tawbi | 39 | 2008-06-01 | 2017-10-03 |
| Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer Core Biopsy, Blood Collection, Paclitaxel - Breast Cancer | Terminated | Hoosier Cancer Research Network | 11 | 2007-09-01 | 2017-01-25 |
Neoplasm Metastasis (3) · Breast Neoplasms (2) · Carcinoma, Intraductal, Noninfiltrating (1) · Hodgkin Disease (1) · Leukemia, Myelomonocytic, Chronic (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1) · Melanoma (1) · Pancreatic Neoplasms (1) · Skin Neoplasms (1) · Thyroid Diseases (1) · Thyroid Nodule (1)
National Cancer Institute (NCI) (2) · Hoosier Cancer Research Network (1) · Hussein Tawbi (1) · Jonsson Comprehensive Cancer Center (1) · Kafrelsheikh University (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · Northwestern University (1) · Yale University (1)
United States (9)
Alda L Tam (1) · George Sledge, M.D. (1) · Hussein Tawbi, MD (1) · Lajos Pusztai, M.D., D.Phil (1) · Mia C Weiss (1) · Patricia M LoRusso (1) · Seema A Khan, M.D. (1) · Thomas E Witzig, M.D. (1) · Zev A Wainberg (1)
PMID 32996592, PMID 33927108, PMID 37467452, PMID 39352751, PMID 39863139
P30CA060553 (1), P50CA097274 (1), UM1CA186686 (1), UM1CA186689 (1)